NASDAQ:PMN
ProMIS Neurosciences Inc.
ProMIS Neurosciences Inc. reported net income of −$39.7M in fiscal 2025. The diluted share count rose 66.0%.Summary generated from ProMIS Neurosciences Inc.'s SEC filings. Latest annual report filed Mar 25, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−521.6%
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count change+66.0%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Operating income | −8 | −23 | −14 | −17 | −40 |
| Net income | −10 | −18 | −13 | 3 | −40 |
| Free cash flow | −9 | −17 | n/a | n/a | n/a |
Recent filings
- 4Insider transaction report
Oct 6, 2026 - 8-KResults of operations and financial condition
Aug 13, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 13, 2026 - 4Insider transaction report
Aug 7, 2026 - 8-KRegulation FD disclosure
Jul 28, 2026 - 8-KDirector or officer change
May 20, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 12, 2026 - 8-KResults of operations and financial condition
May 12, 2026